Today: 1 February 2026
Subscribe
Browse Category

Business Strategy News 7 November 2025 - 20 November 2025

UAMY Stock Skyrockets on $245M Pentagon Deal – Bubble or Buy?

UAMY Stock Today (Nov 19, 2025): United States Antimony Slides as Management Highlights Strategy at Southwest IDEAS Conference

Nov 19, 2025 — Shares of United States Antimony Corporation (NYSE American: UAMY) traded lower on Wednesday while management presented at the 17th Annual Southwest IDEAS Conference and reiterated key growth initiatives tied to U.S. critical‑minerals policy and new commercial contracts. Key takeaways for today What UAMY told investors today At the Southwest IDEAS Conference (Nov 19–20, Dallas), UAMY’s leadership…
20 November 2025
···
Nokia Oyj (NOK) Reboots for the AI Supercycle: New Strategy, 2028 Profit Target and Deep Restructuring Shake Markets

Nokia Oyj (NOK) Reboots for the AI Supercycle: New Strategy, 2028 Profit Target and Deep Restructuring Shake Markets

On 19 November 2025, Nokia Oyj used its long-awaited Capital Markets Day in New York to unveil a sweeping AI‑centric strategy, a new 2028 profit target and a major overhaul of its operating model — and investors immediately weighed in. The company is promising a step‑change in profitability and tighter focus on AI infrastructure, but Nokia’s shares fell sharply as…
19 November 2025
····
Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Published November 19, 2025 Target (NYSE: TGT) is heading into the critical holiday shopping season under intense pressure after reporting another quarter of declining sales, trimming its profit outlook and unveiling an ambitious turnaround plan built around price cuts, store upgrades and new AI partnerships — including a shopping app inside ChatGPT. Q3 2025 earnings: sales slip, profit holds up…
19 November 2025
···
Apple CEO Succession 2026: Tim Cook’s Possible Exit, John Ternus’ Rise – and How Much Money Is on the Line

Apple CEO Succession 2026: Tim Cook’s Possible Exit, John Ternus’ Rise – and How Much Money Is on the Line

Published: November 17, 2025 Apple is quietly edging toward the most consequential leadership change since Steve Jobs handed the reins to Tim Cook in 2011. Over the past three days, a wave of reports citing the Financial Times and The Information say Apple’s board has accelerated CEO succession planning, with hardware chief John Ternus emerging as the clear internal favorite…
17 November 2025
···
Amaze Holdings (AMZE) Completes The Food Channel Acquisition; Plans Platform Revamp for Culinary Creators — Nov 12, 2025

Amaze Holdings (AMZE) Soars on Q3 2025 Earnings as Revenue Jumps 1,884% and Creator-Commerce Strategy Accelerates

Published: November 14, 2025 Amaze Holdings, Inc. (NYSE American: AMZE) lit up the micro-cap tech screens on Friday after reporting third-quarter 2025 results showing a 1,884% year‑over‑year revenue surge and outlining an aggressive path to profitability built around AI‑powered creator commerce. The stock spiked more than 50% intraday on extremely heavy volume as traders digested the numbers and a week…
14 November 2025
···
Milestone Scientific (MLSS) Soars on Q3 2025 Earnings, Cost Cuts and Board Shake-Up – Latest for 14 November 2025

Milestone Scientific (MLSS) Soars on Q3 2025 Earnings, Cost Cuts and Board Shake-Up – Latest for 14 November 2025

Milestone Scientific Inc. (NYSE American: MLSS) is back on traders’ radar today after a sharp after‑hours spike, strong pre‑market performance and fresh Q3 2025 numbers that show progress on costs but lingering listing‑compliance and funding risks. Key headlines on Milestone Scientific today As of Friday, 14 November 2025, these are the main developments around Milestone Scientific: MLSS stock today: big…
14 November 2025
····
Merck to Buy Cidara Therapeutics for $9.2 Billion in Bold Bet on Long‑Acting Flu Prevention

Merck to Buy Cidara Therapeutics for $9.2 Billion in Bold Bet on Long‑Acting Flu Prevention

Merck & Co. (NYSE: MRK) has agreed to acquire Cidara Therapeutics (Nasdaq: CDTX) in a deal valued at about $9.2 billion, a blockbuster move that gives the pharma giant a late‑stage, long‑acting influenza prevention drug as it prepares for life after cancer juggernaut Keytruda. Reuters Key points at a glance Deal terms: a rich premium for a single late‑stage asset…
14 November 2025
···
Paysafe (PSFE) Tumbles After Q3 2025 Earnings Miss, Guidance Cut and New Endava AI Partnership

Paysafe (PSFE) Tumbles After Q3 2025 Earnings Miss, Guidance Cut and New Endava AI Partnership

London / New York – November 13, 2025 — Paysafe Limited (NYSE: PSFE) is in the spotlight today after releasing its third‑quarter 2025 results, slashing its full‑year outlook and unveiling a new multi‑year AI‑driven payments partnership with Endava. The mixed update has triggered a sharp sell‑off in PSFE stock despite solid underlying revenue growth. Stock Titan Key takeaways for PSFE…
13 November 2025
··
Anthropic’s Private Shares Soar to $185 Amid AI Frenzy – $183B Valuation, Major Deals & $1.5B Lawsuit

Anthropic Poised to Beat OpenAI to Profitability as It Diversifies Beyond Nvidia — What’s New Today (Nov. 12, 2025)

Key Points at a Glance What the New Profitability Forecasts Tell Us Internal projections shared with investors show starkly different roads to the black for the two most closely watched AI startups. Anthropic outlines a path to break‑even in 2028, whereas OpenAI doesn’t project profitability until 2030. The figures were surfaced in a Wall Street Journal analysis and amplified by…
12 November 2025
····
Marriott Terminates Sonder Partnership After ‘Default’: Bonvoy Bookings Halted, 2025 Room‑Growth Outlook Trimmed

Marriott Ends Sonder Partnership After ‘Default,’ Cuts 2025 Net Rooms Growth Outlook to ~4.5% — What Travelers & Investors Need to Know (Nov 10, 2025)

Published: November 10, 2025 Summary: Marriott International has terminated its licensing agreement with short‑term‑rental operator Sonder after a “default,” removed Sonder listings from Marriott Bonvoy channels, and trimmed its 2025 net rooms growth outlook to ~4.5%. Here’s the latest on guest impacts, financial guidance, and what to do if you had an upcoming stay. What happened Marriott International said its…
10 November 2025
·
Metsera (NASDAQ: MTSR): Pfizer Clinches $10B Deal as Novo Nordisk Bows Out — What to Know Today (Nov. 8, 2025)

Pfizer Clinches $10B Takeover of Metsera as Novo Nordisk Bows Out — Full Terms, Timeline, and What It Means (Nov. 8, 2025)

Metsera (NASDAQ: MTSR) and Pfizer struck an amended deal worth up to $10B after Novo Nordisk exited the bidding. Here are the final terms, key dates, and what investors should watch next. Updated: November 8, 2025 Top takeaways What changed on Nov. 7–8 Friday, Nov. 7: Metsera announced an amended merger agreement with Pfizer at $86.25 per share (comprised of…
8 November 2025
···
Wendy’s (WEN) pops after Q3 beat as ‘Project Fresh’ adds store-closure plan — Nov. 7, 2025

Wendy’s (WEN) pops after Q3 beat as ‘Project Fresh’ adds store-closure plan — Nov. 7, 2025

The Wendy’s Company (NASDAQ: WEN) beat Q3 estimates, declared a $0.14 dividend, outlined 2025 guidance, and said a mid‑single‑digit percentage of U.S. restaurants could close under its new “Project Fresh” turnaround. Here’s what investors need to know today. Wendy’s delivered an earnings beat this morning and doubled down on a major turnaround called Project Fresh. Results were mixed: international momentum…
7 November 2025
···
1 2 3 4 5 6 7

Stock Market Today

  • Austevoll Seafood Stock Review: Valuation, Returns, and Market Outlook
    February 1, 2026, 12:00 PM EST. Austevoll Seafood (OB:AUSS) has shown mixed recent share performance with a 1.53% gain in the last week but a 6.17% decline over 30 days. The 1-year total return is negative at -10.24%, contrasting with positive returns over 3 and 5 years. The company reported growing annual revenue of NOK 38,995 million and net income of NOK 1,339 million. Current share price is NOK 92.7, below the fair value estimate of NOK 108.50, indicating potential undervaluation. Growth hinges on rising demand for high-protein seafood and expanding higher-value products. Risks include seafood price volatility and regulatory changes in Chile. Investors should weigh short-term weakness against longer-term prospects amid shifting consumer trends.
Go toTop